Tamsulosin administration for prophylaxis and treatment of stent-related symptoms
- Authors: Martov AG1, Maksimov VA1, Ergakov DV1, Miroshnikov VM1, Asfandiyarov FR1, Kalashnikov ES1, Martov AG1, Maximov VA1, Ergakov DV1, Miroshnikov VM1, Asfandiyarov FR1, Kalashnikov ES1
-
Affiliations:
- Issue: No 1 (2010)
- Pages: 3-8
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/277503
- ID: 277503
Cite item
Full Text
Abstract
About the authors
A G Martov
V A Maksimov
D V Ergakov
V M Miroshnikov
F R Asfandiyarov
E S Kalashnikov
A G Martov
V A Maximov
D V Ergakov
V M Miroshnikov
F R Asfandiyarov
E S Kalashnikov
References
- Зенков С. С. Внутреннее дренирование верхних мочевых путей: Дис. ... канд. мед. наук. М.; 1998.
- Мартов А. Г., Долгушин Б. И., Меринов Д. В. и др. Стентирование для восстановления проходимости верхних мочевыводящих путей. В кн.: Сосудистое и внутриорганное стентирование: Руководство. М.: Грааль; 326-343.
- Ringel A., Richter S., Shalev M., Nissenkom I. Late complications of ureteral stents. Eur. Urol. 2000; 36: 41-44.
- Damiano R., Oliva A., Esposito C. et al. Early and late complications of double pigtail ureteral stent. Urol. Int. 2002; 69: 136-140.
- Lee C., Kuskowski M., Premoli J. et al. Randomized evaluation of ureteral stents using validated symptom questionnaire. J. Endourol. 2005; 19: 990-993.
- Deliveliotis C., Chrisofos M., Gougousis E. et al. Is there a role for alpha-blockers in treating double-J related symptoms? Urology 2006; 67: 35-39.
- Michel M. C., de la Rosette J. J. Efficacy and safety of tamsulosin in the treatment of urological diseases. Expert. Opin. Pharmacother. 2004; 5: 151-160.
- Autorino R., De Sio M., Damiano R. et al. The use of tamsulosin in the medical treatment of ureteral calculi: Where do we stand? Urol. Res. 2005; 33: 460-464.
- Joshi H. B., Newns N., Stainhorpe A. et al. Ureteral stent symptom questionnaire: development and validation of multidimensional quality of life measure. J. Urol. (Baltimore) 2003; 169: 1060-1064.
- Nabi G., Cook J., N'Dow J. et al. Outcomes of stenting after uncomplicated ureteroscopy: systematic review and meta-analysis. Br. Med. J. 2007; 334: 572.
- Paz A., Amiel G. D., Pick N. et al. Febrile complications following insertion of 100 double J-ureteral stents. J. Endourol. 2005; 19: 147-150.
- Damiano R., Autorino R., De Sio M. et al. Effect of tamsulosin in preventing ureteral stent-related morbidity: A prospective study. J. Endourol. 2008; 22 (4): 651-655.
- Thomas R. Indwelling ureteral stents: Impact of material and shape on patient comfort. J. Endourol. 1993; 7: 137-140.
- Joshi H. B., Chitale S. V., Nagarajan M. et al. A prospective randomized single-blind comparison of ureteral stent composed of firm and soft polymer. J. Urol. (Baltimore) 2005; 174: 2303- 2306.
- Rane A., Saleemi A., Cahill D. et al. Have stent-related symptoms anything to do with placement technique? J. Endourol. 2001; 15: 741-745.
- Beiko D. T., Watterson J. D., Knudsen B. E. et al. Double-blind randomized controlled trial assessing the safety and efficacy of intravesical agents for ureteral stents symptoms after extracorporeal shockwave lithotripsy. J. Endourol. 2004; 18: 723-730.
- Мартов А. Г., Гущин Б. Л., Ощепков В. Н., Ергаков Д. В. Применение α1-адреноблокаторов для лечения нарушений мочеиспускания у больных после трансуретральной резекции предстательной железы. Урология 2002; 5 (прил.): 23-37.
Supplementary files
